A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Brompheniramine
Pirfenidone
The risk or severity of adverse effects can be increased when Budesonide is combined with Pirfenidone.
Brompheniramine
Brequinar
The risk or severity of adverse effects can be increased when Budesonide is combined with Brequinar.
Brompheniramine
2-Methoxyethanol
The risk or severity of adverse effects can be increased when Budesonide is combined with 2-Methoxyethanol.
Brompheniramine
Vorinostat
The risk or severity of adverse effects can be increased when Budesonide is combined with Vorinostat.
Brompheniramine
Castanospermine
The risk or severity of adverse effects can be increased when Budesonide is combined with Castanospermine.
Brompheniramine
Hydroxychloroquine
The risk or severity of adverse effects can be increased when Budesonide is combined with Hydroxychloroquine.
Brompheniramine
Stepronin
The risk or severity of adverse effects can be increased when Budesonide is combined with Stepronin.
Brompheniramine
Nelarabine
The risk or severity of adverse effects can be increased when Budesonide is combined with Nelarabine.
Brompheniramine
Decitabine
The risk or severity of adverse effects can be increased when Budesonide is combined with Decitabine.
Brompheniramine
Eculizumab
The risk or severity of adverse effects can be increased when Budesonide is combined with Eculizumab.
Brompheniramine
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Budesonide.
Brompheniramine
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Budesonide.
Brompheniramine
Flucytosine
The risk or severity of adverse effects can be increased when Flucytosine is combined with Budesonide.
Brompheniramine
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Budesonide.
Brompheniramine
Mycophenolic acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Budesonide.
Brompheniramine
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Budesonide.
Brompheniramine
Azacitidine
The risk or severity of adverse effects can be increased when Azacitidine is combined with Budesonide.
Brompheniramine
Dacarbazine
The risk or severity of adverse effects can be increased when Dacarbazine is combined with Budesonide.
Brompheniramine
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Budesonide.
Phensuximide
Selpercatinib
The serum concentration of Anastrozole can be increased when it is combined with Selpercatinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3